A2M has a current difference in providing 100% A2 milk , i guess they could command a premium for their product provided consumers are sold on the benefits if any of A2 protein only IMF (Infant Milk Formula) - that would involve a lot of money spent on marketing and research to back up their claims. If A2M was to dominate sales because of A2 protein only product then other producers of IMF would also move to a A2 protein only product - does A2M own a global patent preventing others from selling A2 protein IMF only product.
https://en.wikipedia.org/wiki/A2_milk
"The company marketing A2 milk claims that milk containing A1 proteins are harmful, but a 2009 European Food Safety Authority (EFSA) review of scientific literature found there was insufficient evidence to prove that bioactive peptides in A1 milk have a negative effect on health."
"A2 milk is not a milk substitute for infants with cow milk protein allergies"
http://www.illawarramercury.com.au/story/2551233/nutritionist-questions-a2-milks-health-claims/
"A2's nutrition manager Sonja Kukuljan said the Curtin trial was a "fact-finding mission" aimed at helping direct further research funding." - has there been any more research done to back up A2M's claims since Sept 2014.
- Forums
- ASX - By Stock
- A2M - 'Overweight' and 'Buy' rating from LightForce - 12 Month Target AUD 2.00/share
A2M has a current difference in providing 100% A2 milk , i guess...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$5.91 |
Change
0.010(0.17%) |
Mkt cap ! $4.278B |
Open | High | Low | Value | Volume |
$6.03 | $6.07 | $5.90 | $11.65M | 1.965M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5500 | $5.90 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.91 | 2504 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 11972 | 5.890 |
2 | 31393 | 5.880 |
2 | 12054 | 5.870 |
2 | 9980 | 5.860 |
3 | 1150 | 5.850 |
Price($) | Vol. | No. |
---|---|---|
5.910 | 2504 | 1 |
5.920 | 8176 | 2 |
5.940 | 4146 | 1 |
5.960 | 12222 | 4 |
5.970 | 24200 | 5 |
Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online